Schisandrin A alleviates non-alcoholic fatty liver disease by improving liver metabolic disorders and suppressing the GSK3β signaling pathway - Li Zong; Rui Xu; Yunxia Sun; Junjie Qiu; Huihui Tao; Chengyu Shentu; Hongxia Niu; Tengfei Xu; Yuan Zhou (Food Bioscience, 2024)